As of 2026-01-20, the EV/EBITDA ratio of Biodesix, Inc. (BDSX) is -2.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biodesix,'s latest enterprise value is 73.98 mil USD. Biodesix,'s TTM EBITDA according to its financial statements is -25.96 mil USD. Dividing these 2 quantities gives us the above Biodesix, EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 9.1x | 7.7x |
| Forward P/E multiples | 5.3x - 9.0x | 7.4x |
| Fair Price | (36.89) - (47.90) | (41.19) |
| Upside | -568.1% - -707.9% | -622.8% |
| Date | EV/EBITDA |
| 2025-12-24 | -2.62 |
| 2025-12-23 | -2.61 |
| 2025-12-22 | -2.62 |
| 2025-12-19 | -2.60 |
| 2025-12-18 | -2.68 |
| 2025-12-17 | -2.78 |
| 2025-12-16 | -2.85 |
| 2025-12-15 | -2.77 |
| 2025-12-12 | -2.84 |
| 2025-12-11 | -2.88 |
| 2025-12-10 | -2.90 |
| 2025-12-09 | -2.94 |
| 2025-12-08 | -2.83 |
| 2025-12-05 | -2.81 |
| 2025-12-04 | -2.99 |
| 2025-12-03 | -2.90 |
| 2025-12-02 | -2.84 |
| 2025-12-01 | -2.83 |
| 2025-11-28 | -2.93 |
| 2025-11-26 | -2.85 |
| 2025-11-25 | -2.82 |
| 2025-11-24 | -2.73 |
| 2025-11-21 | -2.63 |
| 2025-11-20 | -2.56 |
| 2025-11-19 | -2.64 |
| 2025-11-18 | -2.70 |
| 2025-11-17 | -2.86 |
| 2025-11-14 | -2.87 |
| 2025-11-13 | -2.85 |
| 2025-11-12 | -2.86 |
| 2025-11-11 | -2.95 |
| 2025-11-10 | -2.78 |
| 2025-11-07 | -2.82 |
| 2025-11-06 | -2.83 |
| 2025-11-05 | -3.00 |
| 2025-11-04 | -2.79 |
| 2025-11-03 | -2.52 |
| 2025-10-31 | -2.63 |
| 2025-10-30 | -2.57 |
| 2025-10-29 | -2.56 |
| 2025-10-28 | -2.57 |
| 2025-10-27 | -2.59 |
| 2025-10-24 | -2.60 |
| 2025-10-23 | -2.54 |
| 2025-10-22 | -2.45 |
| 2025-10-21 | -2.63 |
| 2025-10-20 | -2.58 |
| 2025-10-17 | -2.54 |
| 2025-10-16 | -2.65 |
| 2025-10-15 | -2.75 |